Abstract
To increase resistance to important grapevine pathogens, Chardonnay was transformed with a construct containing two antimicrobial peptides (AMPs), Magainin-2 and PGL. Five lines expressing Magainin-2 transcripts showed increased resistance to two strains of Agrobacterium vitis, TM4 and CG450. These results led to a comprehensive study of the effects of nine AMPs on in vitro growth of four pathogens: two bacterial (A. tumefaciens and A. vitis strains CG450 and TM4) and two fungal (Botrytis cinerea and Erysiphe necator). Cecropin B, MSI-99, and Shiva 1 were most effective against the two A. vitis strains, but ESF-12 had no effect. The growth of TM4 was always more sensitive to AMPs than was CG450, a pattern commensurate with the observations of crown gall resistance among transformed vines expressing Magainin-2. Botrytis cinerea required more than 10 μM α-Purothionin, PGL, or ESF39 for effective growth inhibition. None of the AMPs studied could reproducibly control E. necator spore germination or lesion formation. MSI-99 and Cecropin B were most promising for future increased resistance to crown gall disease in transgenic grapevines.
- antimicrobial peptide
- Vitis vinifera
- Agrobacterium vitis
- Botrytis cinerea
- genetic transformation
- Erysiphe necator
- Received July 2009.
- Revision received February 2010.
- Accepted April 2010.
- Published online September 2010
- Copyright © 2010 by the American Society for Enology and Viticulture
Sign in for ASEV members
ASEV Members, please sign in at ASEV to access the journal online.
Sign in for Institutional and Non-member Subscribers
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 2 day for US$10.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.